Combined Magnetization Transfer and Proton Spectroscopic Imaging in the Assessment of Pathologic Brain Lesions in Multiple Sclerosis

References

1. ↵
   Wallace CJ, Seland TP, Fong TC. Multiple sclerosis: the impact of MR imaging. AJR Am J Roentgenol 1992;158:849-857

   PubMed
2. Miller DH. Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol 1994;36:S91-S94
3. ↵
   Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24

   Abstract/FREE Full Text
4. ↵
   Truyen L, van Waesberghe JH, van Walderveen MA,, et al. Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476

   Abstract/FREE Full Text
5. van Walderveen MA, Kamphorst W, Scheltens P,, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288

   Abstract/FREE Full Text
6. ↵
   Valk J, de Slegte RG, Crezee FC, Hazenberg GJ, Thjaha SI, Nauta JJ. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA. Acta Radiol 1987;28:659-665

   PubMedWeb of Science
7. Miller DH, Barkhof F, Nauta JJ. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993;116(Pt 5):1077-1094

   Abstract/FREE Full Text
8. Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials. Ann Neurol 1994;36(Suppl):S86-S90
9. Filippi M, Campi A, Martinelli V,, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:540-544

   Abstract/FREE Full Text
10. ↵
    Armspach JP, Gounot D, Rumbach L, Chambron J. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 1991;9:107-113

    CrossRefPubMedWeb of Science
11. MacKay A, Whittall K, Adler J, Li D, Paty D, Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 1994;31:673-677

    CrossRefPubMedWeb of Science
12. Vavasour IM, Whittall KP, MacKay AL, Li DKB, Vorobeychik G, Paty DW. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients. Magn Reson Med 1998;40:763-768

    PubMedWeb of Science
13. ↵
    Christiansen P, Gideon P, Thomsen C, Stubgaard M, Henriksen O, Larsson HB. Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand 1993;87:195-199

    PubMedWeb of Science
14. Horsfield MA, Larsson HB, Jones DK, Gass A. Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64:S80-S84
15. ↵
    Wolinsky JS, Narayana PA, Fenstermacher MJ. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 1990;40:1764-1769

    Abstract/FREE Full Text
16. Grossman RI, Lenkinski RE, Ramer KN, Gonzalez-Scarano F, Cohen JA. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992;13:1535-1543

    Abstract/FREE Full Text
17. Davie CA, Hawkins CP, Barker GJ,, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117(Pt 1):49-58

    Abstract/FREE Full Text
18. Hirsch JA, Lenkinski RE, Grossman RI. MR spectroscopy in the evaluation of enhancing lesions in the brain in multiple sclerosis. AJNR Am J Neuroradiol 1996;17:1829-1836

    Abstract
19. Arnold DL, Wolinsky JS, Matthews PM, Falini A. The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64:S94-S101
20. De Stefano N, Matthews PM, Fu L,, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121:1469-1477

    Abstract/FREE Full Text
21. ↵
    Dousset V, Grossman RI, Ramer KN,, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491

    PubMedWeb of Science
22. ↵
    Pike GB, Glover GH, Hu BS, Enzmann DR. Pulsed magnetization transfer spin-echo MR imaging. J Magn Reson Imaging 1993;3:531-539

    PubMedWeb of Science
23. ↵
    Gass A, Barker GJ, Kidd D,, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-67

    CrossRefPubMedWeb of Science
24. Mehta RC, Pike GB, Enzmann DR. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. AJNR Am J Neuroradiol 1996;17:1051-1055

    Abstract
25. van Buchem MA, Udupa JK, McGowan JC,, et al. Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR Am J Neuroradiol 1997;18:1287-1290

    Abstract
26. Petrella JR, Grossman RI, McGowan JC, Campbell G, Cohen JA. Multiple sclerosis lesions: relationship between MR enhancement pattern and magnetization transfer effect. AJNR Am J Neuroradiol 1996;17:1041-1049

    Abstract
27. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814

    CrossRefPubMedWeb of Science
28. ↵
    Edzes HT, Samulski ED. The measurement of cross-relaxation effects in the proton NMR spin-lattice relaxation of water in biological systems: hydrated collagen and muscle. J Magn Reson 1978;31:207-229

    CrossRefWeb of Science
29. Fung B. Nuclear magnetic resonance study of water interactions with proteins, biomolecules, membranes, and tissues. In: Packer L, ed. Methods in Enzymology. San Diego: Academic Press; 1986;127:151
30. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10:135-144

    CrossRefPubMedWeb of Science
31. Hu BS, Conolly SM, Wright GA, Nishimura DG, Macovski A. Pulsed saturation transfer contrast. Magn Reson Med 1992;26:231-240

    PubMed
32. Yeung HN, Aisen AM. Magnetization transfer contrast with periodic pulsed saturation. Radiology 1992;183:209-214

    PubMed
33. Pike GB. Pulsed magnetization transfer contrast in gradient echo imaging: a two-pool analytic description of signal response. Magn Reson Med 1996;36:95-103

    CrossRefPubMedWeb of Science
34. ↵
    Tanttu JI, Sepponen RE, Lipton MJ, Kuusela T. Synergistic enhancement of MRI with GdDTPA and magnetization transfer. J Comput Assist Tomogr 1992;16:19-24

    PubMedWeb of Science
35. Mehta RC, Pike GB, Haros SP, Enzmann DR. Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging. Radiology 1995;195:41-46

    PubMed
36. Elster AD, Mathews VP, King JC, Hamilton CA. Improved detection of gadolinium enhancement using magnetization transfer imaging. Neuroimaging Clin N Am 1994;4:185-192

    PubMed
37. Mathews VP, Elster AD, King JC, Ulmer JL, Hamilton CA, Strottmann JM. Combined effects of magnetization transfer and gadolinium in cranial MR imaging and MR angiography. AJR Am J Roentgenol 1995;164:169-172

    PubMed
38. van Waesberghe JH, Castelijns JA, Roser W,, et al. Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions. AJNR Am J Neuroradiol 1997;18:1279-1285

    Abstract
39. Silver NC, Good CD, Barker GJ,, et al. Sensitivity of contrast enhanced MRI in multiple sclerosis: effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 1997;120(Pt 7):1149-1161

    Abstract/FREE Full Text
40. ↵
    Koenig SH. Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain. Magn Reson Med 1991;20:285-291

    PubMedWeb of Science
41. ↵
    Koenig SH, Brown RD, Spiller M, Lundbom N. Relaxometry of brain: why white matter appears bright in MRI. Magn Reson Med 1990;14:482-495

    PubMedWeb of Science
42. ↵
    Ceckler TL, Wolff SD, Simon A, Yip V, Balaban RS. Dynamic and chemical factors affecting water proton relaxation by macromolecules. J Magn Reson 1992;98:637-645

    CrossRef
43. ↵
    Kucharczyk W, Macdonald PM, Stanisz GJ, Henkelman RM. Relaxivity and magnetization transfer of white matter lipids in MR imaging: importance of cerebrosides and pH. Radiology 1994;192:521-529

    PubMedWeb of Science
44. ↵
    Koller KJ, Zaczek R, Coyle JT. N-acetyl-aspartyl glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43:1136-1142

    PubMedWeb of Science
45. Coyle JT, Robinson MB, Blakely RD, Forloni GL. The neurobiology of N-acetyl-aspartyl glutamate. In: Allosteric Modulation of Amino Acid Receptors: Therapeutic Implications. New York: Raven Press; 1989:319–333
46. Gill SS, Small RK, Thomas DG,, et al. Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2:196-200

    PubMed
47. ↵
    Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991;41:1251-1256

    Abstract/FREE Full Text
48. ↵
    Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31:235-241

    CrossRefPubMedWeb of Science
49. Preece NE, Butter C, Gadian DG, Urenjak J, Baker D. 1H-NMR studies of CNS metabolism in a guinea pig model of multiple sclerosis. In: Proceedings of the Tenth Annual Meeting of the SMRM. San Francisco: Society of Magnetic Resonance in Medicine; 1991:432
50. ↵
    De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721-727

    PubMedWeb of Science
51. ↵
    De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901-909

    CrossRefPubMedWeb of Science
52. ↵
    Hiehle JF Jr, Lenkinski RE, Grossman RI,, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 1994;32:285-293

    PubMedWeb of Science
53. ↵
    Kimura H, Grossman RI, Lenkinski RE, Gonzalez-Scarano F. Proton Mr spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. AJNR Am J Neuroradiol 1996;17:1539-1547

    Abstract
54. ↵
    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale. Neurology 1983;33:1444-1452

    Abstract/FREE Full Text
55. ↵
    Poser CM, Paty DW, Scheinberg L,, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231

    CrossRefPubMedWeb of Science
56. ↵
    Ordidge RJ, Mansfield P, Prime JAL. Volume selection using gradients and selective pulses. Ann N Y Acad Sci 1987;508:376-385

    PubMedWeb of Science
57. ↵
    den Hollander JA, Oosterwal B, Vroonhoven HV, Luyten PR. Elimination of magnetic field distortions in 1H NMR spectroscopic imaging. In: Proceedings of the Society of Magnetic Resonance in Medicine. San Francisco: Society of Magnetic Resonance in Medicine; 1991:472
58. ↵
    Davies SE, Newcombe J, Williams SR, McDonald WI, Clark JB. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995;64:742-748

    PubMedWeb of Science
59. Husted CA, Goodin DS, Hugg JW,, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31p and 1H spectroscopic imaging. Ann Neurol 1994;36:157-165

    CrossRefPubMedWeb of Science
60. Pan JW, Hetherington HP, Vaughan JT, Mitchell G, Pohost GM, Whitaker JN. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn Reson Med 1996;36:72-77

    PubMedWeb of Science
61. ↵
    Kamber M. Automated Detection of Multiple Sclerosis Lesions in Magnetic Resonance Images of the Human Brain.. Concordia University; 1991. Thesis
62. ↵
    Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized talairach space. J Comput Assist Tomogr 1994;18:192-205

    CrossRefPubMedWeb of Science
63. Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511-515

    PubMedWeb of Science
64. Filippi M, Campi A, Dousset V,, et al. A magnetization transfer imaging study of normal appearing white matter in multiple sclerosis. Neurology 1995;45(Pt 1):478-482

    Abstract/FREE Full Text
65. ↵
    Lexa FJ, Grossman RI, Rosenquist AC. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. AJNR Am J Neuroradiol 1994;15:201-212

    Abstract/FREE Full Text
66. ↵
    Mehta RC, Pike GB, Enzmann DR. Magnetization transfer MR of the normal adult brain. AJNR Am J Neuroradiol 1995;16:2085-2091

    Abstract
67. ↵
    Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain 1991;114(Pt 3):1271-1280

    Abstract/FREE Full Text
68. ↵
    Pike GB, De Stefano N, Narayanan S, Francis G, Antel J, Arnold DL. A longitudinal study of magnetization transfer in multiple sclerosis. In: Proceedings of the International Society for Magnetic Resonance in Medicine. Sydney, Australia: International Society for Magnetic Resonance in Medicine; 1998:122
69. Filippi M, Paty DW, Kappos L,, et al. Correlations between changes in disability and T2-weighted brain. Neurology 1995;45:255-260

    Abstract/FREE Full Text
70. Gasperini C, Horsfield MA, Thorpe JW,, et al. Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters. J Magn Reson Imaging 1996;6:580-584

    PubMedWeb of Science
71. Paty DW, Li DK. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: ii: MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial: UBC MS/MRI study group and the IF NB multiple sclerosis study group (comments). Neurology 1993;43:662-667

    Abstract/FREE Full Text
72. ↵
    Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magn Reson Med 1993;29:759-766

    PubMedWeb of Science